The number of circulating CD45+CD34+CD133+ progenitors in COPD patients was not related to the disease severity, as there were no differences among patients with moderate, severe and very severe COPD according to the spirometric GOLD stage (Figure 2A). This evidence concerns the gene PROM1 and chronic obstructive pulmonary disease.